Northern Trust’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

Northern Trust’s Portfolio NVOS Stock Details NVOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-27,905	Closed	-$7.84K	–	4544
2024 Q3	$7.84K	Hold	27,905	–	–	﹤0.01%	4393
2024 Q2	$20.9K	Hold	27,905	–	–	﹤0.01%	4328
2024 Q1	$13.6K	Hold	27,905	–	–	﹤0.01%	4370
2023 Q4	$22.9K	Buy	27,905 +3,224	+13%	+$6.55K	﹤0.01%	4351
2023 Q3	$73.6K	Buy	24,681 +15,792	+178%	+$28.8K	﹤0.01%	4080
2023 Q2	$13.2K	Hold	8,889	–	–	﹤0.01%	4459
2023 Q1	$10.9K	Buy	+8,889	New	+$11.8K	﹤0.01%	4514

Other funds holding NVOS

ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

Northern Trust's NVOS Position: Q4 2024 in Review

Northern Trust sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q4 2024, closing a stake of 27,905 shares — an estimated $7.84K sold.

Northern Trust first reported a position in NVOS in Q1 2023 and held it in 7 quarters. The position peaked at $73.6K in Q3 2023. 1 fund tracked by Wall St. Rank holds NVOS as of Q4 2024.

Northern Trust reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Northern Trust sold 27,905 Novo Integrated Sciences, Inc. Common Stock shares in Q4 2024, an estimated $7.84K.
Northern Trust first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q1 2023 and held it in 7 quarters.
Northern Trust's Novo Integrated Sciences, Inc. Common Stock position peaked at $73.6K in Q3 2023.
1 fund tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q4 2024.

Based on Northern Trust's 13F filing for Q4 2024, filed 14 Feb 2025.